JPMorgan raised the firm’s price target on Cinemark (CNK) to $38 from $37 and keeps an Overweight rating on the shares as part of a Q3 earnings preview for the cinema group. The firm reduced its Q3 and 2025 box office outlook but has increased conviction in 2026 estimates after taking an early look at the first half release slate.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Positive Outlook for Cinemark Holdings Driven by Strong Film Lineup, Financial Position, and Strategic Diversification
- Taylor Swift plans return to movie theaters, Hollywood Reporter says
- Cinemark, Rokt expand partnership
- Cinemark management to meet with Benchmark
- Cinemark Holdings: Positioned for Rebound and Long-term Growth Amid Strategic Financial Moves